Compare Organon & Co. Common Stock (OGN) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Prudential Financial Inc — how do they compare? Organon & Co. Common Stock trades at $13.73 (market cap $3.61B), while Prudential Financial Inc trades at $114.45 (market cap $39.15B). The key difference: Prudential Financial Inc is far larger — about 10.8× Organon & Co. Common Stock's market cap, and Prudential Financial Inc pays the higher dividend (4.93%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Prudential Financial Inc for 146 Days on average.
| OGN | PRU | |
|---|---|---|
Market Cap | $3.61B | $39.15B |
Volume | 1,808,049 | 1,633,697 |
Sector | Health | Financials |
52-Week High | $13.81 | $125.13 |
52-Week Low | $5.70 | $92.00 |
Typical Hold Time | 0 Days | 146 Days |
Enterprise Value | $11.03B | $67.93B |
Dividend Yield | 0.58% | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Prudential Financial (PRU) trades at $113.41, showing minimal daily movement with a 0.02% gain. The stock presents mixed signals with bearish technical indicators but solid fundamentals including a P/E of 10.29 and ROE of 12.46%. Recent earnings show two consecutive beats, while the company executes strategic initiatives including a $185 million Alexforbes stake sale and rebranding to Prudential Wealth Advisors.
PRU offers value investor appeal with attractive valuation metrics and dividend income, though analyst consensus leans heavily toward Hold (67.57%) with a $105.56 price target below current levels. Key risks include execution of the $3 billion capital rotation plan and sensitivity to interest rate changes, while opportunities exist in annuity market growth and cost reduction initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
